Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data Viatris (Nasdaq: VTRS), a global healthcare company, today announced that five abstracts from its Phase 3 program evaluating novel fast-acting formulation of meloxicam (MR-107A-02) in moderate-to-severe acute surgical pain models will be presented at the […]

Using minimally invasive surgery and blood tests Break Through Cancer TeamLab found cancer cells, new drug targets, and biological clues for future therapies Survival rates for advanced ovarian cancer have remained stagnant for over four decades, largely because it so often recurs. While patients respond well to initial surgery and chemotherapy, it comes back in

Biosil® partners with Kelly Rutherford to celebrate its 30th anniversary with the launch of the Biosil Hotline, a fresh brand identity, four new product innovations, and the latest chapter of science-backed beauty solutions Global beauty supplement leader Biosil® proudly unveils its 30th anniversary campaign, fronted by actress and wellness advocate Kelly Rutherford. For three decades,

New Orders and Backlogs Contracting; Production Growing and Employment Contracting; Supplier Deliveries Faster; Raw Materials Inventories Contracting; Customers' Inventories Too Low; Prices Increasing; Exports and Imports Contracting Economic activity in the manufacturing sector contracted in July for the fifth consecutive month, following a two-month expansion preceded by 26 straight months of contraction, say the nation's

Today, we are proud to announce the 2025 recipients of ourGrantTank funding initiative! At The Jensen Project, we know that meaningful change doesn't happen overnight. We believe in long-term and life-changing work that requires consistency, trust, and sustained support. These five carefully vetted grantees were selected for their visionary approaches to addressing commercial sexual exploitation,

Mabwell (688062.SH),an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received Investigational New Drug (IND) application acceptance from China's National Medical Products Administration (NMPA) and an IND Acknowledgement Letter from the U.S. Food and Drug Administration (FDA). 7MW4911 is an investigational CDH17-targeting ADC developed using Mabwell's

The following is being released by A.B. Data, Ltd., the Notice Administrator for the Ray v. NCAA class action lawsuit. Legal Notice Did You Work as a Volunteer Coach in an NCAA Division I Athletics Program in a Sport Other Than Baseball Between March 17, 2019 and June 30, 2023? You Could Be Part of

(NASDAQ:NEO), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors have engaged

(NASDAQ:EXEL), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. (“Exelixis” or the “Company”) (NASDAQ: EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors have engaged

(NASDAQ:DUOL), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Duolingo and certain of its officers and/or directors have engaged